IMARC Group, a leading market research company, has recently releases report titled “Artificial Intelligence in Life Sciences Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global artificial intelligence in life sciences market size, growth, share, trends, and forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Industry Overview of Artificial Intelligence in Life Sciences
Artificial intelligence (AI) in life sciences refers to the utilization of machine learning (ML) algorithms and data-driven techniques to analyze complex biological and medical data. It encompasses a wide range of technologies, including natural language processing, computer vision, and predictive analytics, to make sense of vast datasets generated in research and clinical settings. It automates tasks that would be time-consuming for humans, allowing healthcare professionals to focus on more complex aspects of their work. It aids researchers in sifting through extensive datasets to identify patterns, uncover biomarkers, and gain deeper insights into complex biological processes. It enhances the accuracy and speed of medical diagnoses, particularly in radiology and pathology. It can identify anomalies in medical images, such as tumors, fractures, or infections, with high precision. It assesses patient risk factors, predicts disease progression, and recommends personalized treatment strategies, leading to more effective healthcare.
How Big Is the Artificial Intelligence in Life Sciences Market?
The global artificial intelligence in life sciences market size reached US$ 1.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 8.2 Billion by 2028, exhibiting a growth rate (CAGR) of 25.7% during 2023-2028.
Request Sample Copy of This Report: https://www.imarcgroup.com/artificial-intelligence-in-life-sciences-market/requestsample
What are the growth prospects and trends in the artificial intelligence in life sciences industry?
At present, the increasing employment of AI to streamline research processes, reduce errors, and lower drug development costs represents one of the crucial factors impelling the market growth. Additionally, the rising volume of biological and healthcare data, including genomics, electronic health records (EHR), and medical imaging, is driving the demand for AI solutions for efficient analysis and interpretation. Besides this, the growing focus on AI-powered diagnostic tools for early disease detection and improving the accuracy of medical imaging analysis is offering a favorable market outlook.
Moreover, the increasing utilization of AI to optimize pharmaceutical manufacturing processes, leading to improved quality control and reduced production costs, is supporting the market growth. In addition, the rising number of collaborations between technology companies and life sciences firms is fostering innovation and expanding the role of AI in the industry.
Furthermore, the growing adoption of AI-powered chatbots and virtual assistants is enhancing patient engagement by providing personalized healthcare recommendations and reminders, improving overall patient care. Apart from this, the increasing emphasis on patient data security and privacy is driving the need for AI to develop robust encryption and authentication solutions.
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Offering:
- Software
- Hardware
- Services
Breakup by Deployment:
- On-premises
- Cloud-based
Breakup by Application:
- Drug Discovery
- Medical Diagnosis
- Biotechnology
- Clinical Trials
- Precision and Personalized Medicine
- Patient Monitoring
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Who are the key players operating in the industry?
The report covers the major market players including:
- AiCure LLC
- Apixio Inc. (Centene Corporation)
- Atomwise Inc
- Enlitic Inc.
- International Business Machines Corporation
- Insilico Medicine Inc.
- Nuance Communications Inc.
- NuMedii Inc.
- Sensely Inc.
- Sophia Genetics SA
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: [email protected]
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
